A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

NCT04494984 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
243
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Inmunova S.A.